Posts by: Magdalena Kegel

Magdalena Kegel

Magdalena is a writer with a passion for bridging the gap between the people performing research, and those who want or need to understand it. She writes about medical science and drug discovery. She holds an MS in Pharmaceutical Bioscience and a PhD — spanning the fields of psychiatry, immunology, and neuropharmacology — from Karolinska Institutet in Sweden.

September 19, 2017

Gaucher Disease Guidance Could Help Non-specialists Diagnosis It Better, Study Reports

Doctors who are not Gaucher disease experts should have straightforward and easy-to-follow diagnosis guidance so patients can be treated earlier, according to a study reporting that it can take ... Read more

July 27, 2017July 27, 2017

Poor Bone Health in Gaucher Disease May Be Unrelated to the Condition Itself, Study Reports

Poor bone health in people with Gaucher disease is likely driven by processes independent of the condition, researchers at Argentina’s National University of La Plata report. They identified the prime suspects ... Read more

July 25, 2017

Long-term Follow-up Needed to Assess Newborn Screening for Lysomal Storage Disorders

The benefits of newborn screening for lysosomal storage disorders such as Gaucher disease were not directly apparent 15 months after Illinois launched statewide screening. Long-term follow-up is needed to ... Read more

July 11, 2017July 11, 2017

Recommendations on Genetic Counseling for Gaucher-Parkinson’s Link Are Needed, Researchers Argue

Although people with Gaucher disease have a higher risk of developing Parkinson’s disease later in life, the link between the two diseases is rarely addressed in a genetic counseling setting. ... Read more

July 6, 2017

FDA, EMA Propose Exploring Innovative Solutions for Gaucher Disease Drug Development

Regulatory agencies in the U.S. and Europe have joined forces to develop a proposal with the aim to spur innovative approaches in the development of new Gaucher disease treatments. The ... Read more

June 13, 2017June 13, 2017

Introduction of Enzyme Replacement Therapy with Cerezyme Has Significantly Decreased Severe GD1 Complications, Study Shows

The presence of severe complications of Gaucher disease type 1 (GD1) at the time a patient starts treatment has steadily dropped since the introduction of enzyme replacement therapy with ... Read more

April 4, 2017April 4, 2017

Newborns Can Be Screened for Gaucher’s Disease, Chinese Study Shows

A noninvasive way of screening newborns for Gaucher disease, using dried blood spots, is both efficient and feasible, according to a recent Chinese study. Besides making early treatment possible so ... Read more

March 21, 2017

Study in Monkeys Identifies Ambroxol as Possible Therapy for Gaucher Disease

Researchers suggest that a compound called ambroxol should be explored in clinical trials as a potential drug for Gaucher disease. Their study in non-human primates showed that the drug increased ... Read more

February 21, 2017

Gaucher Disease Genetic Screening Does More Good Than Harm, Researchers Argue

Genetic screening for Gaucher disease identifies many patients that may never experience symptoms, according to a new study, and researchers argue that the benefits of early diagnosis of potentially harmful ... Read more

December 20, 2016

Repurposed Drugs to Restore Lysosomal Acidity May Be Used to Treat Gaucher Disease

Making lysosomes more acidic may be an ingeniously simple, yet efficient, way to prevent the consequences of lysosomal storage disorders such as Gaucher disease. And restoring acidity can be ... Read more